Order Summary

In order to access content on the FENIX Marketplace, you must have an account.

The price for access is $0.00.

Do you have a discount code? Click here to enter your discount code.

Account Information Already have an account? Log in here

LEAVE THIS BLANK

By selecting this, I agree to receive emails from fenix.group.

You will be granted access to your FENIX Library to view the full article after sign up.
RETURN TO HOME

Get the lastest analysis

Know what's happening as soon as it does. Benefit from our analysts' decades of insight and market projection experience to make your next move.
fenix group cover image
Free
 Posted in: Other Sep 03 | 2019FENIX to Host EASD Social Event on Monday Sept 16Access Free Blast
ADA news cover image
Free
 Posted in: Basal Insulin, Bolus Insulin, Glucagon, Glucose Monitoring, Insulin Delivery, Other Jun 06 | 2019New Sanofi CEO; Xeris delayed: SENS approval, InPen-Dexcom; Zeal-BB; vTv; AdociaAccess Free Blast
novo cover image
Free
 Posted in: Basal Insulin May 22 | 2019New Novo QW Insulin Ph1 and Ph2 StudiesAccess Free Blast
janssen cover image
Free
 Posted in: SGLT2i May 22 | 2019CREDENCE Priority Review for Invokana; PDUFA Projected in Late September 2019Access Free Blast
lifescan cover image
Free
 Posted in: Glucose Monitoring May 21 | 2019Lifescan Enters CGM Market with New Partnership; Ty Lee Returns to LifescanAccess Free Blast
lilly and merrill cover image
Free
 Posted in: Dual/triple agonist, GLP-1RA May 15 | 2019Lilly oral dual agonist comments @ BAMLAccess Free Blast
lilly cover image
Free
 Posted in: Basal Insulin, Bolus Insulin, DPP-IVi, Dual/triple agonist, GLP-1RA, Glucagon, Glucose Monitoring, Insulin Delivery, SGLT2i Apr 30 | 2019REWIND Filed; Empa T1DM, Nasal Glucagon Delayed; Lilly Q1 '19 Earnings UpdateAccess Free Blast
Free
 Posted in: Other Nov 14 | 2018Amarin’s REDUCE-IT: Winners, Losers, and Suitors AnalysisAccess Free Blast